27 September 2011
Responding to the published results today of Afinitor® (everolimus) combined with exemestane, Jane Maher, Chief Medical Officer, Macmillan Cancer Support said:
'This trial shows a small but significant step in fighting advanced breast cancer.
'There are thousands of women with incurable breast cancer in the UK. Many of these women are able to live good quality lives with the right treatment and support despite the prognosis. Trials like this are really promising.'
For further information, please contact:
Andrea Shufflebotham, Media & PR Officer of Macmillan Cancer Support
020 7840 4689
About Macmillan Cancer Support:
Macmillan Cancer Support improves the lives of people affected by cancer, providing practical, medical, emotional and financial support. Working alongside people affected by cancer, Macmillan works to improve cancer care. More than one in three of us get cancer. Two million of us are living with it. If you are affected by cancer Macmillan can help.
Every day more people face the toughest fight of their lives. For cancer support every step of the way, or to find out how you can support their work, call Macmillan Cancer Support free on 0808 808 00 00 or visit macmillan.org.uk